Cargando…
Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo
Accumulating evidence suggests that high expression of FGFR1 is closely related to the development of lung cancer especially in non-small cell lung cancers (NSCLC), to which non-ATP competitive inhibitors represent an effective therapeutical approach due to their good specificity. Herein, a series o...
Autores principales: | Wu, Jianzhang, Ji, Jiansong, Weng, Bixia, Qiu, Peihong, Kanchana, Karvannan, Wei, Tao, Wang, Yi, Cai, Yuepiao, Li, Xiaokun, Liang, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147344/ https://www.ncbi.nlm.nih.gov/pubmed/24980830 |
Ejemplares similares
-
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer
por: Wu, Jianzhang, et al.
Publicado: (2015) -
Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression
por: Liu, Yanan, et al.
Publicado: (2020) -
Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells
por: Liu, Zhiguo, et al.
Publicado: (2013) -
Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells
por: Zhang, Xiuhua, et al.
Publicado: (2015) -
Discovery and
Optimization of the First ATP Competitive
Type-III c-MET Inhibitor
por: Michaelides, Iacovos N., et al.
Publicado: (2023)